These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3322813)

  • 1. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.
    de Martin R; Haendler B; Hofer-Warbinek R; Gaugitsch H; Wrann M; Schlüsener H; Seifert JM; Bodmer S; Fontana A; Hofer E
    EMBO J; 1987 Dec; 6(12):3673-7. PubMed ID: 3322813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
    Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
    J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.
    Siepl C; Bodmer S; Frei K; MacDonald HR; De Martin R; Hofer E; Fontana A
    Eur J Immunol; 1988 Apr; 18(4):593-600. PubMed ID: 2452745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.
    Wrann M; Bodmer S; de Martin R; Siepl C; Hofer-Warbinek R; Frei K; Hofer E; Fontana A
    EMBO J; 1987 Jun; 6(6):1633-6. PubMed ID: 3497030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-beta 2 gene reveals striking differences to the TGF-beta 1 and -beta 3 genes.
    Malipiero U; Höller M; Werner U; Fontana A
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1145-51. PubMed ID: 2222434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.
    Kuppner MC; Hamou MF; Sawamura Y; Bodmer S; de Tribolet N
    J Neurosurg; 1989 Aug; 71(2):211-7. PubMed ID: 2545842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma-cell-derived T-cell suppressor factor (G-TsF). Sequence analysis and biologic mechanism of G-TsF.
    Siepl C; Bodmer S; Hofer E; Wrann M; Frei K; Fontana A
    Ann N Y Acad Sci; 1988; 540():437-9. PubMed ID: 3264676
    [No Abstract]   [Full Text] [Related]  

  • 8. The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.
    Kuppner MC; Hamou MF; Bodmer S; Fontana A; de Tribolet N
    Int J Cancer; 1988 Oct; 42(4):562-7. PubMed ID: 3262591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?
    Fontana A; Bodmer S; Frei K; Malipiero U; Siepl C
    Ciba Found Symp; 1991; 157():232-8; discussion 238-41. PubMed ID: 1649035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of another member of the transforming growth factor type beta gene family.
    ten Dijke P; Hansen P; Iwata KK; Pieler C; Foulkes JG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4715-9. PubMed ID: 3164476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta 2: cDNA cloning and sequence analysis.
    Madisen L; Webb NR; Rose TM; Marquardt H; Ikeda T; Twardzik D; Seyedin S; Purchio AF
    DNA; 1988; 7(1):1-8. PubMed ID: 3162414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The murine transforming growth factor-beta precursor.
    Derynck R; Jarrett JA; Chen EY; Goeddel DV
    J Biol Chem; 1986 Apr; 261(10):4377-9. PubMed ID: 3007454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific T cell suppressor factor (TsF): isolation of a cDNA clone encoding for a functional polypeptide chain of phosphorylcholine-specific TsF.
    Sugimura K; Yamasaki N; Matsuura M; Watanabe T
    Eur J Immunol; 1985 Sep; 15(9):873-80. PubMed ID: 2412834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human transforming growth factor-alpha: precursor structure and expression in E. coli.
    Derynck R; Roberts AB; Winkler ME; Chen EY; Goeddel DV
    Cell; 1984 Aug; 38(1):287-97. PubMed ID: 6088071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta.
    Skonier J; Neubauer M; Madisen L; Bennett K; Plowman GD; Purchio AF
    DNA Cell Biol; 1992 Sep; 11(7):511-22. PubMed ID: 1388724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-beta 1.
    Van Obberghen-Schilling E; Kondaiah P; Ludwig RL; Sporn MB; Baker CC
    Mol Endocrinol; 1987 Oct; 1(10):693-8. PubMed ID: 3153459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.
    Derynck R; Jarrett JA; Chen EY; Eaton DH; Bell JR; Assoian RK; Roberts AB; Sporn MB; Goeddel DV
    Nature; 1985 Aug 22-28; 316(6030):701-5. PubMed ID: 3861940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-beta messenger ribonucleic acid from chick embryo chondrocytes.
    Jakowlew SB; Dillard PJ; Kondaiah P; Sporn MB; Roberts AB
    Mol Endocrinol; 1988 Aug; 2(8):747-55. PubMed ID: 3211158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of the porcine transforming growth factor-beta precursor.
    Derynck R; Rhee L
    Nucleic Acids Res; 1987 Apr; 15(7):3187. PubMed ID: 3470708
    [No Abstract]   [Full Text] [Related]  

  • 20. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
    Huber D; Philipp J; Fontana A
    J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.